Search results

News

Clinical Trials Arena: CRO Altasciences Works With Alzamend for Phase IIa Trial in Alzheimer's

Jun 22, 2023

ISSUE NO. 22 — Nanomilling for Better Solubility and Improved Bioavailability

Feb 21, 2022

• Manufacturing and Analytical Services

Scientific Publication

Leveraging Nonclinical Safety Evaluation Findings to Expedite Next-Generation Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) Development for Metabolic Disorders and Beyond

Nov 21, 2024

• Preclinical Research

Scientific Publication

GLP-1 RA: Rapid Clinical Phase I Study Execution

Nov 21, 2024

• Clinical Trials

Altasciences’ Commitment to Bioanalytical Excellence

Nov 13, 2024

• Bioanalysis
• Clinical Trials
• End-to-End Program
• Manufacturing and Analytical Services
• Preclinical Research
• Research Support

Discover the Dynamic Landscape of GLP-1 Drug Development

Nov 11, 2024

• End-to-End Program
• Preclinical Research
• Clinical Trials
• Manufacturing and Analytical Services
• Bioanalysis

Sensitive ASO Quantitation for Decentralized Trials

Nov 7, 2024

• Bioanalysis